Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aditxt Inc (ADTX)

Aditxt Inc (ADTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,432
  • Shares Outstanding, K 14,688
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,150 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ADTX with:

Options Overview

Details
  • Implied Volatility 143.63%
  • Historical Volatility 50.39%
  • IV Percentile 61%
  • IV Rank 42.45%
  • IV High 214.86% on 03/02/21
  • IV Low 91.09% on 07/22/21
  • Put/Call Vol Ratio 0.44
  • Today's Volume 89
  • Volume Avg (30-Day) 262
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 13,367
  • Open Int (30-Day) 11,897

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.10 +1.90%
on 07/30/21
2.96 -27.70%
on 07/23/21
-0.45 (-17.37%)
since 06/30/21
3-Month
2.10 +1.90%
on 07/30/21
3.20 -33.12%
on 05/03/21
-0.72 (-25.17%)
since 04/30/21
52-Week
1.62 +32.10%
on 09/24/20
9.58 -77.66%
on 08/06/20
-1.66 (-43.68%)
since 07/30/20

Most Recent Stories

More News
Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19

Aditxt, Inc. ("Aditxt") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced enhancements to its AditxtScore(TM) for COVID-19. A multi-dimensional...

ADTX : 2.14 (-4.04%)
Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtScore(TM) Center in Richmond, VA. This high-capacity,...

ADTX : 2.14 (-4.04%)
Aditxt Announces the Appointment of Dr. Lauren Chung to its Board of Directors

Aditx Therapeutics, Inc. ("Aditxt") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today that Dr. Lauren Chung will join the Aditxt board...

ADTX : 2.14 (-4.04%)
Aditxt Set to Join Russell Microcap® Index

/PRNewswire/ -- ("Aditxt") (NASDAQ: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced that it is set to join the Russell Microcap® Index,...

ADTX : 2.14 (-4.04%)
Aditxt Signs Channel Partner Agreement with Meridian HSN to Make AditxtScore™ for COVID-19 Available to its Network of Healthcare Provider Partners

, /PRNewswire/ --  (Aditxt) (the "Company") (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Meridian Health Services Network (Meridian...

ADTX : 2.14 (-4.04%)
Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA

and , /PRNewswire/ -- Aditxt (Aditx Therapeutics, Inc.) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced plans to build a high-capacity...

ADTX : 2.14 (-4.04%)
Aditxt Therapeutics Names Sunny Uberoi as its first Chief Communications Officer

, /PRNewswire/ -- Aditx Therapeutics, Inc. (Aditxt) (the "Company") (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that has joined...

ADTX : 2.14 (-4.04%)
HealthBar Becomes AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring to Complement its Concierge and Drive-Thru Testing Services

, /PRNewswire/ --  (Aditxt) (the "Company") (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that HealthBar will be offering AditxtScore™...

ADTX : 2.14 (-4.04%)
Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring through its Mobile Testing Centers

, /PRNewswire/ -- Aditx Therapeutics, Inc. (Aditxt) (the "Company") (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Collection...

COPRF : 0.0550 (-3.85%)
ADTX : 2.14 (-4.04%)
Collection Sites, LLC Named AditxtScore(TM) Channel Partner to Offer AditxtScore(TM) for COVID-19 Immunity Status Monitoring Through Its Mobile Testing Centres

Medivolve Inc. ("Medivolve") (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer AditxtScore(TM) for COVID-19 through its mobile testing centres....

ADTX : 2.14 (-4.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Aditx Therapeutics Inc. is a life sciences company. It engages in developing biotechnologies specifically focused on health of the immune system through immune monitoring and reprogramming. Aditx Therapeutics Inc. is based in LOMA LINDA, CA.

See More

Key Turning Points

3rd Resistance Point 2.48
2nd Resistance Point 2.39
1st Resistance Point 2.27
Last Price 2.14
1st Support Level 2.06
2nd Support Level 1.97
3rd Support Level 1.85

See More

52-Week High 9.58
Fibonacci 61.8% 6.54
Fibonacci 50% 5.60
Fibonacci 38.2% 4.66
Last Price 2.14
52-Week Low 1.62

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar